[go: up one dir, main page]

FI104178B1 - 17-spirofuran-3'-ylideenisteroidit - Google Patents

17-spirofuran-3'-ylideenisteroidit

Info

Publication number
FI104178B1
FI104178B1 FI925790A FI925790A FI104178B1 FI 104178 B1 FI104178 B1 FI 104178B1 FI 925790 A FI925790 A FI 925790A FI 925790 A FI925790 A FI 925790A FI 104178 B1 FI104178 B1 FI 104178B1
Authority
FI
Finland
Prior art keywords
lower alkyl
hydrogen
spirofuran
ylidensteroider
acyl
Prior art date
Application number
FI925790A
Other languages
English (en)
Swedish (sv)
Other versions
FI925790L (fi
FI104178B (fi
FI925790A0 (fi
Inventor
Johannes Antonius Mar Hamersma
Everardus Otto Maria Orlemans
Johannes Bernardus Ma Rewinkel
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI925790A0 publication Critical patent/FI925790A0/fi
Publication of FI925790L publication Critical patent/FI925790L/fi
Application granted granted Critical
Publication of FI104178B publication Critical patent/FI104178B/fi
Publication of FI104178B1 publication Critical patent/FI104178B1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36Antigestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
FI925790A 1991-12-20 1992-12-18 17-spirofuran-3'-ylideenisteroidit FI104178B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91203366 1991-12-20
EP91203366 1991-12-20

Publications (4)

Publication Number Publication Date
FI925790A0 FI925790A0 (fi) 1992-12-18
FI925790L FI925790L (fi) 1993-06-21
FI104178B FI104178B (fi) 1999-11-30
FI104178B1 true FI104178B1 (fi) 1999-11-30

Family

ID=8208088

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925790A FI104178B1 (fi) 1991-12-20 1992-12-18 17-spirofuran-3'-ylideenisteroidit

Country Status (17)

Country Link
US (1) US5292878A (fi)
EP (1) EP0549041B1 (fi)
JP (1) JP3462515B2 (fi)
KR (1) KR100287513B1 (fi)
AT (1) ATE128983T1 (fi)
AU (1) AU655858B2 (fi)
CA (1) CA2084431C (fi)
DE (1) DE69205405T2 (fi)
DK (1) DK0549041T3 (fi)
ES (1) ES2081040T3 (fi)
FI (1) FI104178B1 (fi)
GR (1) GR3018630T3 (fi)
HK (1) HK1002033A1 (fi)
MX (1) MX9207394A (fi)
NO (1) NO302525B1 (fi)
NZ (1) NZ245520A (fi)
ZA (1) ZA929315B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
CN1281363A (zh) * 1997-11-14 2001-01-24 阿克佐诺贝尔公司 孕激素-抗孕激素体系
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
SK15502001A3 (sk) * 1999-04-29 2002-03-05 Akzo Nobel N. V. Použitie Org 33245
US6043235A (en) * 1999-07-21 2000-03-28 Research Triangle Institute 11β-aryl-17, 17-spirothiolane-substituted steroids
US7426602B2 (en) * 2004-01-08 2008-09-16 Topside Research, Llc Switch for bus optimization
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
AU2007217095B2 (en) * 2006-02-17 2012-05-03 Janssen Pharmaceutica N.V. 17-phosphorous steroid derivatives useful as progesterone receptor modulators
WO2007098381A2 (en) * 2006-02-17 2007-08-30 Janssen Pharmaceutica N.V. 11-phosphorous steroid derivatives useful as progesterone receptor modulators
HUE036870T2 (hu) 2006-10-24 2018-08-28 Repros Therapeutics Inc Az endometriális proliferáció elnyomására szolgáló készítmények és módszerek
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
US8673968B2 (en) * 2009-04-06 2014-03-18 Evestra, Inc. Progesterone antagonists
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
CN101926806A (zh) * 2009-06-24 2010-12-29 天津金耀集团有限公司 一种17磷类雌甾化合物在制备紧急避孕药物中的应用
US20130018027A1 (en) 2010-03-22 2013-01-17 Repros Therapeutics Inc. Compositions and methods for non-toxic delivery of antiprogestins
US20130272956A1 (en) * 2010-06-17 2013-10-17 Franciscus Theodorus Leonardus Brands (11beta, 17alpha)-11-(4-(2-11C-ACETYL)PHENYL)-17,23-EPOXY-19,24-DINORCHOLA-4,9,20-TRIEN-3-ONE
US9096641B2 (en) 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3461090D1 (en) * 1983-02-18 1986-12-04 Schering Ag 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
EP0254341B1 (en) * 1986-07-23 1990-01-03 Akzo N.V. Novel 18-phenyloestrane derivatives
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
EP0289073B1 (en) * 1987-04-24 1991-11-27 Akzo N.V. Novel 11-aryloestrane and 11-arylpregnane derivatives
ES2053714T3 (es) * 1987-12-12 1994-08-01 Akzo Nv Proceso para la preparacion de 11-arilesteroides.

Also Published As

Publication number Publication date
NZ245520A (en) 1995-02-24
FI925790L (fi) 1993-06-21
NO924857D0 (no) 1992-12-15
HK1002033A1 (en) 1998-07-24
NO302525B1 (no) 1998-03-16
EP0549041B1 (en) 1995-10-11
ZA929315B (en) 1993-05-24
CA2084431C (en) 2003-04-08
DE69205405D1 (de) 1995-11-16
NO924857L (no) 1993-06-21
AU3009392A (en) 1993-06-24
ATE128983T1 (de) 1995-10-15
EP0549041A1 (en) 1993-06-30
FI104178B (fi) 1999-11-30
JPH05255380A (ja) 1993-10-05
DK0549041T3 (da) 1996-01-29
JP3462515B2 (ja) 2003-11-05
DE69205405T2 (de) 1996-05-09
US5292878A (en) 1994-03-08
MX9207394A (es) 1993-07-30
FI925790A0 (fi) 1992-12-18
KR100287513B1 (ko) 2001-05-02
AU655858B2 (en) 1995-01-12
GR3018630T3 (en) 1996-04-30
CA2084431A1 (en) 1993-06-21
ES2081040T3 (es) 1996-02-16

Similar Documents

Publication Publication Date Title
FI104178B1 (fi) 17-spirofuran-3'-ylideenisteroidit
ATE176237T1 (de) Sphingoglycolipid und verwendung davon
SE9100342D0 (sv) Novel steroid esters
FI955108A0 (fi) Steroideja, jotka sisältävät 17-spiromtyleenilaktoni- tai laktoliryhmän
ATE229968T1 (de) Diagnostisches mittel zur glykostoffwechselfunktion
NO307447B1 (no) Anvendelse av et pregnanderivat
FI821486A0 (fi) 4'-halogensubstituerade sakkarosderivater
ZA907639B (en) Benzanilides
FI823458A0 (fi) Substituerade tiazolidinylestrar av mineralsyror
DK0381989T3 (da) 4-epi-4-amino-anthracycliner
FR2362148A1 (fr) Composes silices polyethyleniques
FR2501676B1 (fi)
ATE73136T1 (de) Verfahren zur herstellung von 6alpha, 9alphadifluor-11beta, 17alpha-dihydroxy-16alpha-methyl4-pregnen-3,20-dion und dessen derivate.
IL117497A (en) 17-difluoromethylene estratriene derivatives and pharmaceutical compositions containing the same
ATE116655T1 (de) 2-acyloxy-4-morpholinyl-anthracyclin.
FI812777L (fi) Foerfarande foer framstaellning av nya cardenolid-bis-digitoxosider
FR2493846B1 (fi)
DE69615814D1 (de) Uch-15-verbindungen

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON